{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:53:23Z","timestamp":1781945603226,"version":"3.54.5"},"reference-count":196,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.det.2023.02.012","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T15:53:04Z","timestamp":1680709984000},"page":"455-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cutaneous Sarcoidosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Nnenna","family":"Ezeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avrom","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotonye","family":"Imadojemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 Pt 1","key":"10.1016\/j.det.2023.02.012_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6, Part 2","key":"10.1016\/j.det.2023.02.012_bib2","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.lpm.2012.02.046","article-title":"Skin manifestations of sarcoidosis","volume":"41","author":"Ma\u00f1\u00e1","year":"2012","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0366-0869(57)80050-1","article-title":"Diagnosis and incidence of sarcoidosis","volume":"51","author":"L\u00f6fgren","year":"1957","journal-title":"Br J Tubercul Dis Chest"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195202000-00001","article-title":"A\u00a0study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital","volume":"31","author":"Longcope","year":"1952","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(63)90165-7","article-title":"Manifestations of sarcoidosis: analysis of 145 patients, with a review of nine series selected from the literature","volume":"35","author":"Mayock","year":"1963","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0954-6111(03)00127-6","article-title":"Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients","volume":"97","author":"Yanarda\u011f","year":"2003","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ijd.12248","article-title":"Cutaneous sarcoidosis: clinicopathologic study of 76 patients from Lebanon","volume":"54","author":"Ishak","year":"2015","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijwd.2021.01.014","article-title":"Prevalence and characteristics of cutaneous sarcoidosis in Argentina","volume":"7","author":"Abed Dickson","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"7","key":"10.1016\/j.det.2023.02.012_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2230.2011.04128.x","article-title":"Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease","volume":"36","author":"Marcoval","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1055\/s-0040-1713130","article-title":"Cutaneous sarcoidosis","volume":"41","author":"Caplan","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40257-014-0079-3","article-title":"A\u00a0practical approach to cutaneous sarcoidosis","volume":"15","author":"Wanat","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.012_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-022-00693-0","article-title":"The evolving landscape of cutaneous sarcoidosis: pathogenic insight, clinical challenges, and new frontiers in therapy","author":"Wu","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.02.012_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in america. analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib17","first-page":"380","article-title":"Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences","volume":"34","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.det.2023.02.012_bib18","doi-asserted-by":"crossref","first-page":"106564","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/qjmed\/hcaa171","article-title":"Sarcoidosis diagnosed in the elderly: a case-control study","volume":"114","author":"Bert","year":"2021","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MD.0b013e3182569f91","article-title":"Late-onset sarcoidosis: a comparative study","volume":"91","author":"Varron","year":"2012","journal-title":"Medicine (Baltim)"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/thoraxjnl-2016-209032","article-title":"Seasonal variation in incidence of sarcoidosis: a population-based study, 1976-2013","volume":"71","author":"Ungprasert","year":"2016","journal-title":"Thorax"},{"issue":"Suppl 1","key":"10.1016\/j.det.2023.02.012_bib23","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2105\/AJPH.2009.171058","article-title":"Critical race theory, race equity, and public health: toward antiracism praxis","volume":"100","author":"Ford","year":"2010","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/pde.14058","article-title":"Structural racism and its influence on the severity of atopic dermatitis in African American children","volume":"37","author":"Tackett","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.acap.2016.11.011","article-title":"Pediatric asthma health disparities: race, hardship, housing, and asthma in a national survey","volume":"17","author":"Hughes","year":"2017","journal-title":"Acad Pediatr"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/002214650804900202","article-title":"Racial\/ethnic differences in asthma prevalence: the role of housing and neighborhood environments","volume":"49","author":"Rosenbaum","year":"2008","journal-title":"J\u00a0Health Soc Behav"},{"key":"10.1016\/j.det.2023.02.012_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.healthplace.2017.01.006","article-title":"Does neighborhood social and environmental context impact race\/ethnic disparities in childhood asthma?","volume":"44","author":"Brewer","year":"2017","journal-title":"Health Place"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jaci.2021.09.020","article-title":"Structural racism and its pathways to asthma and atopic dermatitis","volume":"148","author":"Martinez","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/diagnostics11061089","article-title":"Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes","volume":"11","author":"Saketkoo","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.det.2023.02.012_bib30","doi-asserted-by":"crossref","first-page":"537382","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaad.2021.04.079","article-title":"Increased risk of systemic and cardiac sarcoidosis in Black patients with cutaneous sarcoidosis","volume":"86","author":"Kassamali","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib32","first-page":"128","article-title":"Mortality among African American women with sarcoidosis: data from the Black Women\u2019s Health Study","volume":"30","author":"Tukey","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","article-title":"Sarcoidosis in black women in the United States: data from the Black Women\u2019s Health Study","volume":"139","author":"Cozier","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib34","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib35","doi-asserted-by":"crossref","first-page":"2001160","DOI":"10.1183\/13993003.01160-2020","article-title":"Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort","volume":"57","author":"Lhote","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.det.2023.02.012_bib36","first-page":"236905","article-title":"Sarcoidosis: sex-dependent variations in presentation and management","volume":"2014","author":"Birnbaum","year":"2014","journal-title":"J\u00a0Ophthalmol"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib37","first-page":"166","article-title":"Epidemiology, demographics, and genetics of sarcoidosis","volume":"13","author":"Rybicki","year":"1998","journal-title":"Semin Respir Infect"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2007-970331","article-title":"Epidemiology of sarcoidosis: recent advances and future prospects","volume":"28","author":"Rybicki","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ijd.12633","article-title":"Epidemiology of sarcoidosis in Afro-Caribbean people: a 7-year retrospective study in Guadeloupe","volume":"54","author":"Coquart","year":"2015","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.04.00070503","article-title":"Sarcoidosis: social predictors of severity at presentation","volume":"24","author":"Rabin","year":"2004","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ophtha.2006.05.074","article-title":"Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis","volume":"114","author":"Evans","year":"2007","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib42","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/jdv.13760","article-title":"Epidemiology of cutaneous sarcoidosis, 1976-2013: a population-based study from Olmsted County, Minnesota","volume":"30","author":"Ungprasert","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","article-title":"Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data","volume":"100","author":"Gideon","year":"1996","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib45","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib47","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib48","first-page":"124","article-title":"Hospitalization for patients with sarcoidosis: 1979-2000","volume":"23","author":"Foreman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.det.2023.02.012_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2466-12-19","article-title":"Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study","volume":"12","author":"Gerke","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.amjmed.2019.03.048","article-title":"Disparities in sarcoidosis mortality by region, urbanization, and race in the united states: a multiple cause of death analysis","volume":"132","author":"Ogundipe","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.det.2023.02.012_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2018.11.010","article-title":"Sarcoidosis deaths in the United States: 1999-2016","volume":"149","author":"Kearney","year":"2019","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib52","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1513\/AnnalsATS.201806-401RL","article-title":"Sarcoidosis-associated hospitalizations in the United States, 2002 to 2012","volume":"15","author":"Wills","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/aje\/153.2.188","article-title":"Familial risk ratio of sarcoidosis in African-American sibs and parents","volume":"153","author":"Rybicki","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.det.2023.02.012_bib54","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2007.094060","article-title":"Heredity in sarcoidosis: a registry-based twin study","volume":"63","author":"Sverrild","year":"2008","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib56","doi-asserted-by":"crossref","first-page":"1800385","DOI":"10.1183\/13993003.00385-2018","article-title":"Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study","volume":"52","author":"Rossides","year":"2018","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib57","doi-asserted-by":"crossref","first-page":"E1830","DOI":"10.3390\/ijerph16101830","article-title":"Genetic variants associated with FDNY WTC-related sarcoidosis","volume":"16","author":"Cleven","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/17476348.2019.1655401","article-title":"New concepts in the pathogenesis of sarcoidosis","volume":"13","author":"Bennett","year":"2019","journal-title":"Expet Rev Respir Med"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/rcmb.2014-0227OC","article-title":"Association of HLA-DRB1 with sarcoidosis susceptibility and progression in African Americans","volume":"53","author":"Levin","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/rccm.2112060","article-title":"The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans","volume":"167","author":"Rybicki","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1086\/507847","article-title":"Reduction of sample heterogeneity through use of population substructure: an example from a population of African American families with sarcoidosis","volume":"79","author":"Thompson","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4081\/monaldi.2017.835","article-title":"Association of HLA antigens with the clinical course of sarcoidosis and familial disease","volume":"87","author":"Yanardag","year":"2017","journal-title":"Monaldi Arch Chest Dis"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib63","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/crj.12559","article-title":"Associations between sarcoidosis clinical course and ANXA11 rs1049550 C\/T, BTNL2 rs2076530 G\/A, and HLA class I and II alleles","volume":"12","author":"Morais","year":"2018","journal-title":"Clin Respir J"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib64","first-page":"2633","article-title":"Current insights in genetics of sarcoidosis: functional and clinical impacts","volume":"9","author":"Calender","year":"2020","journal-title":"J\u00a0Clin Monit"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib65","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1165\/rcmb.2015-0278OC","article-title":"Functional toll-like receptor 9 expression and CXCR3 ligand release in pulmonary sarcoidosis","volume":"55","author":"Schnerch","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib66","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1164\/rccm.201507-1344LE","article-title":"Role of NOD2 pathway genes in sarcoidosis cases with clinical characteristics of blau syndrome","volume":"192","author":"Bello","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.det.2023.02.012_bib67","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2017.00422","article-title":"SNP variants in major histocompatibility complex are associated with sarcoidosis susceptibility-a joint analysis in four european populations","volume":"8","author":"Wolin","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib68","first-page":"102","article-title":"The association between ANXA11 gene polymorphisms and sarcoidosis: a meta-analysis and systematic review","volume":"33","author":"Zhou","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib69","doi-asserted-by":"crossref","first-page":"18633","DOI":"10.1038\/s41598-019-54612-1","article-title":"A\u00a0gene-environment interaction between smoking and gene polymorphisms provides a high risk of two subgroups of sarcoidosis","volume":"9","author":"Rivera","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib70","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1007\/s10067-021-05684-w","article-title":"Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis","volume":"40","author":"Fritz","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib71","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib72","first-page":"187","article-title":"The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature","volume":"93","author":"Wang","year":"2020","journal-title":"Yale J Biol Med"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib73","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib75","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/cells9102184","article-title":"IL-12 and IL-23-close relatives with structural homologies but distinct immunological functions","volume":"9","author":"Floss","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib76","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","article-title":"Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acr2.11112","article-title":"Treatment of multiorgan sarcoidosis with tofacitinib","volume":"2","author":"Damsky","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib78","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.012_bib79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.08.012","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis","volume":"16","author":"Talty","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib80","first-page":"262","article-title":"Role of propionibacterium acnes in sarcoidosis: a meta-analysis","volume":"30","author":"Zhou","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7","key":"10.1016\/j.det.2023.02.012_bib81","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamadermatol.2021.1577","article-title":"Granulomatous dermatitis associated with rubella virus infection in an adult with immunodeficiency","volume":"157","author":"Shields","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.det.2023.02.012_bib82","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archderm.141.7.909-b","article-title":"Absence of human herpesvirus 8 in sarcoidosis and crohn disease granulomas","volume":"141","author":"Knoell","year":"2005","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib83","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","article-title":"Is there any association between sarcoidosis and infectious agents?: A systematic review and meta-analysis","volume":"16","author":"Esteves","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib84","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1600-0560.2009.01271.x","article-title":"High prevalence of \u201cBorrelia-like\u201d organisms in skin biopsies of sarcoidosis patients from Western Austria","volume":"36","author":"Derler","year":"2009","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib85","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib86","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.chest.2020.12.027","article-title":"Phase II investigation of the efficacy of antimycobacterial therapy in chronic pulmonary sarcoidosis","volume":"159","author":"Drake","year":"2021","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib87","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.4049\/jimmunol.181.12.8784","article-title":"T\u00a0cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis","volume":"181","author":"Chen","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"3\u20134","key":"10.1016\/j.det.2023.02.012_bib88","first-page":"197","article-title":"Sarcoidosis and autoimmunity: from genetic background to environmental factors","volume":"18","author":"Bindoli","year":"2016","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib89","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.chest.2021.06.003","article-title":"Sarcoidosis: an occupational disease?","volume":"160","author":"Oliver","year":"2021","journal-title":"Chest"},{"issue":"9028","key":"10.1016\/j.det.2023.02.012_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(05)65119-7","article-title":"Granulomatous pneumonitis and mediastinal lymphadenopathy due to photocopier toner dust","volume":"348","author":"Armbruster","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACI.0b013e3283515173","article-title":"Occupational causes of sarcoidosis","volume":"12","author":"Newman","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib92","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A\u00a0case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib93","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00000372-200010000-00004","article-title":"Foreign bodies in sarcoidosis","volume":"22","author":"Kim","year":"2000","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib94","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2017.10.014","article-title":"Clinical course of sarcoidosis in world trade center-exposed firefighters","volume":"153","author":"Hena","year":"2018","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib95","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib96","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Musaelyan","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.det.2023.02.012_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA-DRB1\u221703(+) patients with pulmonary sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/0002764213487340","article-title":"Racism and health I: pathways and scientific evidence","volume":"57","author":"Williams","year":"2013","journal-title":"Am Behav Sci"},{"key":"10.1016\/j.det.2023.02.012_bib99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.soc.33.040406.131740","article-title":"The sociology of discrimination: racial discrimination in employment, housing, credit, and consumer markets","volume":"34","author":"Pager","year":"2008","journal-title":"Annu Rev Sociol"},{"issue":"10077","key":"10.1016\/j.det.2023.02.012_bib100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1742058X11000166","article-title":"Conceptualizing racial disparities in health: advancement of a socio-psychobiological approach","volume":"8","author":"Chae","year":"2011","journal-title":"Du Bois Rev"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib102","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-021-01818-5","article-title":"Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis","volume":"22","author":"Ronsmans","year":"2021","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib103","first-page":"138","article-title":"Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population","volume":"32","author":"Janot","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"20","key":"10.1016\/j.det.2023.02.012_bib104","doi-asserted-by":"crossref","first-page":"E3798","DOI":"10.3390\/ijerph16203798","article-title":"Neighborhood deprivation and risks of autoimmune disorders: a national cohort study in Sweden","volume":"16","author":"Li","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.det.2023.02.012_bib105","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2105\/AJPH.2007.126003","article-title":"Racial discrimination and racial identity attitudes in relation to self-rated health and physical pain and impairment among two-spirit American Indians\/Alaska Natives","volume":"99","author":"Chae","year":"2009","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amepre.2013.10.020","article-title":"Discrimination, racial bias, and telomere length in African-American men","volume":"46","author":"Chae","year":"2014","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib107","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.annepidem.2011.10.009","article-title":"Racial discrimination, mood disorders, and cardiovascular disease among black americans","volume":"22","author":"Chae","year":"2012","journal-title":"Ann Epidemiol"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib108","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jadohealth.2015.01.017","article-title":"Discrimination, racial identity, and cytokine levels among African-American adolescents","volume":"56","author":"Brody","year":"2015","journal-title":"J\u00a0Adolesc Health"},{"issue":"1S1","key":"10.1016\/j.det.2023.02.012_bib109","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.amepre.2016.09.026","article-title":"Systemic inflammation in midlife: race, socioeconomic status, and perceived discrimination","volume":"52","author":"Stepanikova","year":"2017","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/josi.12061","article-title":"Everyday discrimination prospectively predicts inflammation across 7-years in racially diverse midlife women: study of women\u2019s health across the nation","volume":"70","author":"Beatty","year":"2014","journal-title":"J\u00a0Soc Issues"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib111","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbi.2009.11.011","article-title":"Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults","volume":"24","author":"Lewis","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib112","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2105\/AJPH.2004.060749","article-title":"Weathering\u201d and age patterns of allostatic load scores among blacks and whites in the United States","volume":"96","author":"Geronimus","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1016\/j.det.2023.02.012_bib113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","article-title":"Stress, adaptation, and disease. Allostasis and allostatic load","volume":"840","author":"McEwen","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib114","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s40615-019-00606-8","article-title":"Vicarious racism stress and disease activity: the black women\u2019s experiences living with lupus (BeWELL) study","volume":"6","author":"Martz","year":"2019","journal-title":"J\u00a0Racial Ethn Health Disparities"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib115","first-page":"1434","article-title":"Racial discrimination, disease activity, and organ damage: the black women\u2019s experiences living with lupus (BeWELL) study","volume":"188","author":"Chae","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib116","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2105\/AJPH.2015.302727","article-title":"Discrimination and cumulative disease damage among african american women with systemic lupus erythematosus","volume":"105","author":"Chae","year":"2015","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib117","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the mTOR, Rac1, and Autophagy Triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib119","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/imt.14.103","article-title":"Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?","volume":"7","author":"Celada","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib121","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12890-020-01345-x","article-title":"Role of fibrocytes and endothelial progenitor cells among low-differentiated CD34+ cells in the progression of lung sarcoidosis","volume":"20","author":"El\u017cbieta","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.det.2023.02.012_bib122","unstructured":"Redissi A., Penmetsa G.K. and Litaiem N., Lupus Pernio. In: StatPearls. StatPearls Publishing, Available at: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536968\/. Accessed June 16, 2022."},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1985.tb04859.x","article-title":"Lupus pernio: a clinico-radiological study of thirty-five cases","volume":"112","author":"Spiteri","year":"1985","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib124","first-page":"361","article-title":"Cutaneous manifestations of sarcoidosis in blacks","volume":"32","author":"Minus","year":"1983","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0738-081X(86)90032-5","article-title":"Cutaneous sarcoidosis: definitions and types of lesions","volume":"4","author":"Elgart","year":"1986","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib126","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1055\/s-0030-1262212","article-title":"Cutaneous sarcoidosis","volume":"31","author":"Marchell","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib127","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.1997.03890380087013","article-title":"Ulcerative sarcoidosis. Case report and review of the literature","volume":"133","author":"Albertini","year":"1997","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib128","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10067-016-3356-0","article-title":"Subcutaneous sarcoidosis: a clinical analysis of nine patients","volume":"35","author":"Ando","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib129","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archinte.1985.00360100071011","article-title":"Cutaneous manifestations of sarcoidosis. Relationships to other organ system involvement, abnormal laboratory measurements, and disease course","volume":"145","author":"Olive","year":"1985","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archderm.1972.01620150078024","article-title":"Psoriasiform sarcoidosis","volume":"106","author":"Burgoyne","year":"1972","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib131","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-4362.1992.tb03950.x","article-title":"Psoriasiform sarcoidosis with ulceration","volume":"31","author":"Mitsuishi","year":"1992","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib132","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1067\/mjd.2000.104679","article-title":"Sarcoidosis of the scalp: a case series and review of the literature","volume":"42","author":"Katta","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.02.012_bib133","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-4362.1999.00839.x","article-title":"Cutaneous sarcoidosis in black South Africans","volume":"38","author":"Jacyk","year":"1999","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.det.2023.02.012_bib134","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/archderm.1997.03890430098013","article-title":"Cutaneous involvement in sarcoidosis. Relationship to systemic disease","volume":"133","author":"Mana","year":"1997","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1346-8138.2010.00900.x","article-title":"Lupus pernio with multiple bone cysts in the fingers","volume":"37","author":"Nagai","year":"2010","journal-title":"J\u00a0Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib136","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0b013e31822e0df0","article-title":"Lupus pernio: sarcoid-specific cutaneous manifestation associated with chronic sarcoid arthropathy","volume":"17","author":"Efthimiou","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib137","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio: results of 116 treatment courses in 54 patients","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.det.2023.02.012_bib138","first-page":"44","article-title":"Scar sarcoidosis: 11 patients with variable clinical features and invariable pulmonary involvement","volume":"826","author":"Atci","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib139","doi-asserted-by":"crossref","first-page":"5 3306","DOI":"10.5070\/D32112029526","article-title":"Sarcoidosis","volume":"21","author":"Martires","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2023.02.012_bib140","series-title":"Sarcoidosis, a clinician\u2019s guide","first-page":"127","article-title":"Cutaneous sarcoidosis","author":"Imadojemu","year":"2019"},{"issue":"Dermatol Sect","key":"10.1016\/j.det.2023.02.012_bib141","first-page":"132","article-title":"Tuberculide of the type called \u201csarcoid\u201d of Darier- Roussy","volume":"5","author":"Adamson","year":"1912","journal-title":"Proc R Soc Med"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib142","article-title":"Subcutaneous sarcoidosis without systemic involvement","volume":"20","author":"O\u2019Neill","year":"2014","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2010.06.068","article-title":"Sarcoidosis: Are there differences in your skin of color patients?","volume":"66","author":"Heath","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"208","key":"10.1016\/j.det.2023.02.012_bib144","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q\u00a0J Med"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib145","first-page":"113","article-title":"Pulmonary sarcoidosis in the Nordic countries 1950-1982. II Course and prognosis","volume":"7","author":"Milman","year":"1990","journal-title":"Sarcoidosis"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib146","first-page":"e2022013","article-title":"Erythema nodosum-like sarcoid lesion: a specific skin manifestation occasionally seen in Japanese sarcoidosis patients","volume":"39","author":"Ishikawa","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib147","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2015.08.010","article-title":"Cutaneous sarcoidosis","volume":"36","author":"Wanat","year":"2015","journal-title":"Clin Chest Med"},{"issue":"6936","key":"10.1016\/j.det.2023.02.012_bib148","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(56)90912-6","article-title":"Erythema nodosum as a manifestation of sarcoidosis","volume":"271","author":"James","year":"1956","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib149","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0190-9622(96)90686-6","article-title":"A\u00a0clinicopathologic approach to gran- ulomatous dermatoses","volume":"35","author":"Rabinowitz","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.012_bib150","first-page":"23","article-title":"Cutaneous sarcoidosis: a histopathological study","volume":"678","author":"Cardoso","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib151","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0303-6987.2004.00157.x","article-title":"The histologic spectrum of cutane- ous sarcoidosis: a study of twenty-eight cases","volume":"31","author":"Ball","year":"2004","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib152","first-page":"485","article-title":"The presence of foreign bodies does not exclude the diagnosis of sarcoidosis","volume":"137","author":"Callen","year":"2001","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib153","first-page":"427","article-title":"Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis","volume":"137","author":"Marcoval","year":"2001","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib154","first-page":"6","article-title":"How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung","volume":"31","author":"Judson","year":"2014","journal-title":"Dis"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamadermatol.2013.60","article-title":"Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis","volume":"149","author":"Rosenbach","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.det.2023.02.012_bib156","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamadermatol.2015.2008","article-title":"Reliability and validity of cutaneous sarcoidosis outcome instruments among dermatolo- gists, pulmonologists, and rheumatologists","volume":"151","author":"Yeung","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib157","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000000596","article-title":"The diagnosis of sarcoidosis","volume":"25","author":"Judson","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.det.2023.02.012_bib158","first-page":"25","article-title":"Systemic evaluation of a potential cutaneous sarcoidosis patient","volume":"303AD","author":"Costabel","year":"2007","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib159","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.det.2018.08.001","article-title":"Advances in inflammatory granu- lomatous skin diseases","volume":"37","author":"Imadojemu","year":"2019","journal-title":"Dermatol Clin"},{"issue":"9323","key":"10.1016\/j.det.2023.02.012_bib160","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","article-title":"Small fibre neuropathy in sarcoidosis","volume":"359","author":"Hoitsma","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib161","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(21)00311-8","article-title":"Misconceptions regarding symptoms of sarcoidosis","volume":"9","author":"Drent","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.det.2023.02.012_bib162","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","article-title":"Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study","volume":"138S","author":"Hendriks","year":"2018","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib163","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/MCP.0000000000000413","article-title":"Small fiber neuropathy: a disabling and underrecognized syndrome","volume":"23","author":"Voortman","year":"2017","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.det.2023.02.012_bib164","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MCP.0000000000000597","article-title":"Nonorgan manifestations of sarcoidosis","volume":"25","author":"Tavee","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib165","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2020.10.021","article-title":"Practice gaps in the evaluation of systemic involvement in patients with cutaneous sarcoidosis presenting to a dermatologist: a retrospective review of 48 patients","volume":"85","author":"Villa-Ruiz","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.012_bib166","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.det.2023.02.012_bib167","doi-asserted-by":"crossref","first-page":"e0223897","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib168","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/ced.14614","article-title":"Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service","volume":"46","author":"Paolino","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2023.02.012_bib169","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(61)90213-3","article-title":"The treatment of sarcoidosis with chloroquine","volume":"30","author":"Morse","year":"1961","journal-title":"Am J Med"},{"issue":"3, Pt 1","key":"10.1016\/j.det.2023.02.012_bib170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","article-title":"Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas","volume":"23","author":"Jones","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib171","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1001\/archdermatol.2011.301","article-title":"Efficacy and safety of apremilast in chronic cutaneous sarcoidosis","volume":"148","author":"Baughman","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib172","first-page":"121","article-title":"Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis","volume":"26","author":"Park","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib173","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2133.1977.tb15068.x","article-title":"Cutaneous sarcoidosis treated with methotrexate","volume":"97","author":"Veien","year":"1977","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib174","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000441-199003000-00002","article-title":"The use of low dose methotrexate in refractory sarcoidosis","volume":"299","author":"Lower","year":"1990","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.det.2023.02.012_bib175","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archinte.1995.00430080088011","article-title":"Prolonged use of methotrexate for sarcoidosis","volume":"155","author":"Lower","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.det.2023.02.012_bib176","doi-asserted-by":"crossref","DOI":"10.1177\/12034754221101361","article-title":"Methotrexate for cutaneous sarcoidosis: a dermatology-based case series of 23 patients","author":"Hrin","year":"2022","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib177","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio: results of 116 treatment courses in 54 patients","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib178","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000221005","article-title":"Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF- alpha antagonists","volume":"219","author":"Thielen","year":"2009","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib179","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ajd.12056","article-title":"Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease","volume":"55","author":"Tu","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13555-012-0011-9","article-title":"A case series of refractory cutaneous sarcoidosis successfully treated with infliximab","volume":"2","author":"Tuchinda","year":"2012","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib181","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archdermatol.2012.1322","article-title":"Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors","volume":"148","author":"Wanat","year":"2012","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.02.012_bib182","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archdermatol.2011.307","article-title":"Successful treatment of lupus pernio with adalimumab","volume":"147","author":"Judson","year":"2011","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib183","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.142.1.17","article-title":"Adalimumab for treatment of cutaneous sarcoidosis","volume":"142","author":"Heffernan","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib184","first-page":"289","article-title":"Sarcoidosis Investi- gators. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial","volume":"32","author":"Baughman","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.det.2023.02.012_bib185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jdcr.2019.02.006","article-title":"Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera","volume":"5","author":"Wei","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.det.2023.02.012_bib186","doi-asserted-by":"crossref","first-page":"1801482","DOI":"10.1183\/13993003.01482-2018","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"20;52","author":"Rotenberg","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib187","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jaad.2019.06.1297","article-title":"Janus kinase inhibitors offer promise for a new era of targeted treatment for granulomatous disorders","volume":"82","author":"Rosenbach","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2023.02.012_bib188","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2020-217271","article-title":"Steroid-resistant sarcoidosis treated with baricitinib","volume":"79","author":"Scheinberg","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.det.2023.02.012_bib189","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/annrheumdis-2019-215387","article-title":"Refractory sarcoidosis-like systemic granulomatosis responding to ruxolitinib","volume":"78","author":"Levraut","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.det.2023.02.012_bib190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00408-021-00436-8","article-title":"Tofacitinib as a steroid-sparing therapy in pulmonary sarcoidosis, an open-label prospective proof-of-concept study","volume":"199","author":"Friedman","year":"2021","journal-title":"Lung"},{"key":"10.1016\/j.det.2023.02.012_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2020.12.021","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil","volume":"9","author":"Alam","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2023.02.012_bib192","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jdcr.2020.11.016","article-title":"Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy","volume":"7","author":"Singh","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib193","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.det.2023.02.012_bib194","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13256-019-2137-1","article-title":"Sarcoid-like phenomenon\u2014ustekinumab induced granulomatous reaction mimicking diffuse metastatic disease: a case report and review of the literature","volume":"13","author":"Gad","year":"2019","journal-title":"J\u00a0Med Case Rep"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/bjd.13365","article-title":"Acute systemic sarcoidosis complicating ustekinumab therapy for chronic plaque psoriasis","volume":"172","author":"Powell","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.012_bib196","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09273948.2019.1569245","article-title":"Poor control of sarcoidosis-related panuveitis with an antibody to IL-23","volume":"28","author":"Thomas","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.det.2023.02.012_bib197","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16451","article-title":"Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis","author":"Hornick","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:47:27Z","timestamp":1760006847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863523000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":196,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0733863523000220"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2023.02.012","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2023.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}